CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42,491 enrolled
Drug / intervention
Mentor Silicone Gel-Filled Breast Implants +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00756652
NCT00756652N/ACompleted

MemoryGel Silicone Gel-Filled Breast Implant Post-Approval Study

Mentor Worldwide, LLC·observational·Posted Sep 22, 2008·Updated Jun 4, 2020

In Brief

An observational study evaluating Mentor Silicone Gel-Filled Breast Implants and Saline Breast Implants for Breast Reconstruction and 2 related conditions. Completed, enrolled 42,491 participants.

Detailed Summary

In November 2006, U.S. Food and Drug Administration (FDA) approved Mentor's MemoryGel silicone gel-filled breast implants for use in women who are undergoing primary or revisional breast augmentation and primary or revisional breast reconstruction surgery. This postapproval study is intended to satisfy one element of FDA's postapproval monitoring requirements. In January 2015, the FDA approved a protocol amendment that limits the scope of data collection for the study to the collection of only secondary procedure/reoperation data for MemoryGel participants.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2008
Enrollment StartNov 1, 2006
Primary CompletionJul 31, 2019
TodayJul 2, 2026
Enrollment to primary: 12.8 yearsPosted 17.8 years ago

Interventions

Mentor Silicone Gel-Filled Breast Implantsdevice

Saline Breast Implantsdevice